こちら - 3D MATRIX [medical technology]
Contents
1. TDM 621 50 300 6 2016 1 3442. KOL Key Opinion Leader TOP 2013 4 3 2013 3 13 2013 4 3 3 0 696 697 2013 2 1 2013 4 TDM 621
3. Scaffold GLP Good Laboratory Practce 5 pH
4. pH bFGF PDGF PuraMatrix R A D 16 RADA16
5. m TDM 621 2014 4 2013 2 IDE 2014 4 2013 5 CE 2014 4 CE m TDM 711 TDM 641 TDM 631
6. CRO PII II 1 2 3
7. TOP Massachusetts Institute of Technology MIT Shuguang Zhang 2004 5 1992 MIT Shuguang Zhang MIT MIT 2001 5 3 D Matrix Inc
8. http7 www sharedresearchjp 30 732 Shared 05Wesearch 2013 7 1 7777 DDS Drug Delivery System
9. 3 201 2 7 201 2 7 31 2012 360 RNA
10. 536 2012 4 9 TDM 621 TDM 621 TOP 24 6 9 19 2013 4 1 TOP
11. MTA m 5 3 II
12. C 1987 C 1 2008 1 30 2008 12 14 6 1 2009 1 30 2010 1 2007 12 160 2008 1 2009 3
13. 2 TOP TOP http7 www sharedresearchjp 31732 Shared 05Wesearch 201377 1 SR 2013 7 1 TOKAI 3167 07 01 13 3076 06 11 13 6730
14. TDM 711 TDM 711 TDM 711 GLP TDM 711 2010
15. TDM 621 TDM 621 PMDA TDM 621 2010 13B1X10105 ne TS O 2009 2009 CO OO NI 3 D Matrix Inc TDM 711 IDE FDA Daewoong Pharmaceutical Co LTD PARTNERSHIP AGREEMENT TDM 621 Excelsior Medical Co Ltd LICENSE AGREEMENT TDM 621 ne TDM 621
16. TDM 711 3 TDM 711 http7Xwww sharedresearchJp 12 32 Shared Wesearch 2013 7 1 7777 a
17. MIT MIT 2014 m
18. 2013 4 2014 4 TDM 621 100 60 70 MIT SR
19. FDA IDE Investigational Device Exempton CE EU EU CE TDM 711 2012 2 15 FDA m TDM 641 m 1 2013 4 3
20. m 2007 10 579 1 448 3DM Investmen LLC Massachusetts Insttute of Technology m 2009 11 500 1 250 4 A1C TAIB JAIC Asian Balanced Private Equity Fund m 2010 9 200 400 mm 2010 9 300 600 m 2011 10 1 352 700 1 http7Xwww sharedresearchJp 24 32 Excelsior Medical Co Ltd Daewoong Pharmaceutical Co LTD gt Gared 6 esearch 2013 7 1
21. DDS DDS
22. 2013 6 m http7 www sharedresearchjp 8 32 Shared 05Wesearch 2013 7 1 7777 1 5 d HFP gt 2013 gt gt DE 2014 5 gt 2016 2015 _KTDMH641 TDM 631 TDM 711 TDM 511 MR 3 D Matrix Ltd Th or i cordial red we PP Em FT ey For He Une of CRF PPPrS EH FR HO PP re rm bry rry re prty rilet 3 C Mt ror rhe Cr A
23. 2017 4 2013 6 2013 4 FDA IDE Investgatonal Device Exempton 2014 4 2015 4 2013 6 2013 5 CE EU EU CE CE 2014 4 CE i 2016 4 2013 6
24. A6K siRNA http7Xwww sharedresearch p 13 32 Shared 8 esearch 2013 7 1 7777 DDS siRNA
25. 4 3 4 I _ eo 7 A lt i i oo _ SW Strengths Weaknesses Strengths m MIT
26. 3 4 1992 MIT Shuguang Zhang R A D 3
27. TOP http7Xwww sharedresearchJp 17 32 s Shared Wesearch 2013 7 1 7777 GL 7 000 00 5 811 5 058 5914 5 931 180 1 173 0 1 171 31 7 n 7 5 000 4 000 3 000 hf Lm 2 Od 1 1 1 000 0U G IP 20 9 169 3 168 6 1 140 100 1 0 Li 1 9 1 0 11 12 13 14 m 170
28. a TDM 621 RADA16 TDM 621 TDM 621 TDM 621 pH gt gt gt THM BB 1 TDM B 1
29. FDA 2012 4 2012 4 12 2012 4 http Awww sharedresearch jp 28 32 Shared 05Wesearch 2013 7 1 7777 1 100 550 300 456 256 477 255 478 TDM 621 TDM 621 1 4538 1 4521
30. SR 1 1QB 1 0BB Q 1 157 21 dd4 11 4 12 4 112 EE bB 157 TD GD 1 eBB 1g HBH 1 75 7777 eg 1 13 qd2 Bb5 19B 1 a 4 1 213 2012 4 3 D Matrix Inc 70 1 2019 4
31. kIT Matrix mc IT SR 2014 MIT MIT MIT 2001 5 3 D Matrix Inc
32. m 5057781 m MIT 3
33. qm 2012 9 5 MIT m 507629 m MIT 3 2
34. 2004 5 2004 10 3 DMatrix Inc LICENSE AND SUPPLY AGREEMENT 3 D Matrix Inc MIT MIT Scientfic Founders 2007 10 3 D Matix Inc a http www sharedresearch jp 25 32 Shared 059esearch 2013 7 1 7777 1992 MIT Shuguang Zhang 2001 MIT 3 D Matix Inc 1 3 D Matrix Inc 2003 MIT
35. TOP 3 D Matix Inc 2004 3 D Matix Inc 2000 4 MBA
36. SiRNA 21 23 RNA siRNA RNA RNAi RNA mRNA MTA Material Transfer Agreement
37. TOP 1 SR
38. m m SR Weaknesses
39. 2013 4 2013 6 13 2013 4 32 977 978 2013 4 19 wm TDM 621 PMDA ISO13485 TDM 621 FDA IDE nvestgatonal Device Exempton CE
40. TDM 631 B a TDM 711
41. m 2016 4 TDM 621 2015 4 1 3 2 3 TDM 621 TDM 621 9 2015 4 SR 201 5 4
42. 1 90 m 2014 4 2014 4 m 2015 4 mm 2014 4 2015 4 m 2014 4 CE EU EU CE 2015 4 2016 4 TDM 641 2014 4 G 2016 4 TDM 631
43. TDM 641 2014 4 TDM 511 13 4 14 4 15 3 156 4 178 4 4 12 5G9 9j5 7B5 1 243 1 137 Ta 1 249 1 385 1 71 BGB 1 558 3 4 5 HO 1 545 3 4 1 5 HO 1 491 1 8 MSR 2013 6 13 2014 4 TDM 621
44. i PuraMatrix Becton Dickinson and Company CPC Scientfic Inc 3 3 2011 5 2009 4
45. D D Asp COOH NH2 A A Ala R R Arg ADME ADME Absorpton Distribution Metabolism Excreton ADME
46. 2007 CSBA 2008 JASDAOQ 2008 2012 7 TOP 2012 4 22 19 39 9 2 7 TOP IR 2 4 TOP http7 www sharedresearchjp 29 32 Shared 05Wesearch 2013 7 1 7777 IDE Investigational Device Exempton FDA i
47. am TDM 621 2011 5 PMDA TDM 621 TDM 621 m TDM 711 2011 7 FDA IDE i 2012 4 1 400 TDM 621
48. http7Xwww sharedresearchJp 9 32 hared Wesearch 2013 7 1 7777 TDM 621 TDM 621 1 CA Informed Consent 2 3
49. m 2013 4 2015 4 2014 4 4 495 3 845 1 691 1 091 1 685 1 085 1 441 936 201 5 4 2013 4 2014 4 2014 4 2014 4 2015 4 TDM 621
50. b TDM 641 TDM 641 TDM 641
51. 2013 5 20 TDM 621 CE http goo gl nYPeO 3 D Matrix Europe SAS TDM 621 CE 2013 5 17 CE EU CE EU EU MDD CE EU I TDM 621
52. 2014 4 2014 4 2015 4 3 amp 12 4 13 13 400 0 0 707 0 0 32 100 0 32 7 1 qo 47 d5 120 92 1 90 123 1 1m1 9 150 104 112 132 134 135 155 201 10 52 210 151 157 do 22 227 1077 Pit 204 155 158 MEG 2 29 EB1 1 0GB 1 1 5 9 2n4 195 159 JE 932 29 28 21 1 070 5 1 1 Bd MSR
53. m 3 D Matrix Tnc 100 m 3 D Matrix Europe SAS 100 sm 3 D Matrix Asia Pte Ltd 100 3 http7Xwww sharedresearch p 15 32 Shared 059esearch 2013 7 1 7777 3 D Matrix Inc 3 Matrix Asia Pe Ltd SG MIT lt
54. TDM 64 1 TDM 641 http7Xwww sharedresearchJp 11 32 s Shared Wesearch 2013 7 1 7777 TDM 64 1 TDM 621 RADA16 TDM 621 2014 4 TDM 64 1 2013 6 2012 2
55. TDM 621 TDM 621 TDM 621 TDM 621 TDM
56. 201 1 5 PMDA TDM 621 2014 4 2013 6 2010 9 17 Daewoong Pharmaceutical Co LTD PARTNERSHIP AGREEMENT Excelsior Medical Co Ltd LICENSE AGREEMENT g 2013 5 29 3 D Matrix Asia Pte Ltd PT Teguhsindo Lestaritama
57. PuraMatrix PuraMatrix a 4 a FA FN a Ty EE EE Ac R A D A R ALD A R A H A R ArD A CONH amp D 1 2 3 4 http www sharedresearch jp 7 32 s Shared Wesearch 2013 7 1 7777
58. 1 000 MR 100 TDM 621 MR 700 Daewoong Pharmaceutcal Co LTD Excelsior Medical Co Ltd PT Teguhsindo Lestaritamma Daewoong Pharmaceutical Co LTD Excelsior Medical Co Ltd 14 000 1cc SR
59. m TDM 71 1 2011 7 FDA IDE 2012 2 m TDM 64 1 2012 2 20 2011 Phase 1
60. 1 8001 TDM 621 Daewoong Pharmaceutical Co LTD Excelsior Medical Co Ltd PT Teguhsindo Lestaritama TDM 641 m 2
61. m TDM 621 PMDA CE FDA m TDM 711 2012 2 15 7 FDA m TDM 64 1 2013 4 i m 2012 201 2 4 2012 6 13
62. RNA 2013 4 2012 7 17 2012 8 31 1 2 4 604 9 208 2012 6 2012 6 18 TDM 711 TDM 711 Forsyth Insttute 2012 2 15
63. 123 2012 4 25 TDM 621 TDM 621 PMDA TDM 621 7
64. c TDM 631 RADA16 TDM 631 TDM 631 TDM 631 TDM 631 TDM 631 X
65. 400 190 210 204 204 am TDM 621 2011 4 1 PMDA TDM 621 TDM 621 m
66. 1999 QASDAQ7774 2002 2370 COO 2003 10 2005 2007 1998 1 2005 2007 2012 7 INSEAD MBA 1996 2006 CSBA
67. Exclusive Patent License Agreement 2004 3 D Matrix Inc LICENSE AND SUPPLY AGREEMENT 3 D Matrix Inc PuraMatrix OD 3 D Matrix Inc 2008 Becton Dickinson and Company SUPPLY AGREEMENT PuraMatrix NADA16 1 1 2004 4 2008 UE TDM 621 Selnelnmnelesl 8 S mm
68. 100 MTA MTT MIT 3 D Matrix Inc 2003 4 MIT Exclusive Patent License Agreement MIT 2004 10 3 D Matrix Inc License and Supply Agreement 3 D Matrix Inc 2007 10 3 D Ma
69. 1 850 3 399 533 766 1 698 272 51 0 434 56 7 2013 4 TDM 621 m TDM 621 PMDA http7 www sharedresearchjp 19 7 32 Shared 05Wesearch 2013 7 1 7777 1 4538 1 4521 TDM 621
70. sr_inquiries sharedresearch jp 09 4 1q 4 11 3 12 4 13 1 4 10 402 158 1 107 32 4 1 4 5 Bh 5 5 5 7 1 7 1 75 1 1 7 9 17 5 9 5 4 9 354 999 1 65H 99 H 5 259 50 510 310 97 1 5465 98 9 551 534 309 97H 1 491 97 9 5 11 257 13 5g 15 18 18 355 183G EFS 26 3 5 5 2 18 4 52 7 EPS 17 3 hPS Qn 0 0 0 Qn 0 0 BPS iQ 5 n 5 1 15 E37 5H9 1 75 2 033 5 2 501 2 4 4 7 5 107 19 2 Q 7 5 5 437 3893 733 1 19H 1 199 3 0
71. PMDA FDA 5 PMDA FDA 6 2 3 7 TDM 621 TDM 711 TDM 641 TDM 631 TDM 511 TDM 621 RADA16 TDM 621 97
72. SR Inc http7Xwww sharedresearchJp 327 32 aed esearch
73. https www release tdnet info inbs 140120130613067547 pdf m 2014 4 2016 4 17 32 http www sharedresearch jp Shared 8 esearch 2013 7 1 7777 2014 4 4 178 4 747 1 658 2 055 1 646 2 049 1 491 1 752 2015 4 8 474 8 006 3 347 3 521 3 341 3 515 2 241 2 222 2016 4 12 569 5 780 5 780 3 668 2014 4 2014 4 2015 4
74. SR Inc SR Inc Shared Research SR Inc SR Inc
75. TDM 621 2011 5 1 4538 10 TDM 621 2012 4 1 4521 TDM 621
76. IDATA Research 30 50 2016 1 344M ci ipaTA 1 600 F M 1 200 1 DOO 800 40Q 20 CTUG CYOT CvOB Crogd CTY1UE CTE CT1EE CT13E CY14E CTISE CY1EE LTS ESTATS m 80 10 m 113 685 11 526 60 10 T 5 6
77. 18 936 2013 4 651 200 651 200 2013 4 9 468 000 6 9 2013 6 TOP Qg 3 10 4 11 4 12 4 13 4 22 4d34 131 547 2 13 18 100 5 FCF 1 21 40 52 231 0 ET 9 1 400 m 5 9 B65 11 10 B 5 20 21 FCF NIFAT B C 457 31 1 139 MMSR
78. 7777 09 4 1 3 11 3 12 13 7 0 4 5B 9 458 0 EPS 2 4 7B7Oa 5BBG 7 105 3 EPS an DFS no Qn nn Qn BPS grj502 1 75B42 120 15B 25 1 107 3 1 1 500 1 500 11 257 13 5Ga 15 188 18 355 18 B 5 EPS 4 5 2 18 4 5 EPS 17 DPS Qn Qn BPS 50 9 8 0 75 1 156 3 537 SR 2011 7 1 100 948 2011 8 1 4 3 792 2012 9 1 2 9 222 2013 6 1 2
79. 2016 4 2014 4 2 015 4 2016 4 2013 5 30 PT Teguhsindo Lestaritama TDM 621 https www release tdnet info inbs 140120130530054075 pdf 3 D Matrix Asia Pte Ltd PT Teguhsindo Lestaritama 2013 5 29
80. 2 055 1 658 2015 4 TDM 621 3 521 3 347 2016 4 2014 4 gt 2015 4 0 2 Mo 5 2015 4 2016 4 12 569 8 474 1 107 354 32 999 2012 4 2013 4 2014 4 2015 4 2016 4 http7 www sharedresearch p 5 32 Shared 8 esear ch 2013 7 1 7777 2013 4 2014 4 2014 4 lt 2015 4 2 628 2 508 io 034 1 5CMD 1 031 1 000 753 500 1 24
81. 2012 4 2 201 1 12 9 2012 4 2 2 400 TDM 621 400 341 59 9 9 2 535 2011 4 1 385 685 2011 10 24 JASDAQ 2011 10 23 676
82. http7Xwww sharedresearch p 16 32 hared Wesearch 2013 7 1 7777 TDM 621 2009 2014 4 4 5 RADA16
83. 3 2 2013 6 FDA 510 k 510 k C DDS DDS DDS DbFGF PDGF
84. amp 1 4502 2009 Medmarket Diligence 1 4503 lt 1 3401 gt CSL 1 4559 AH
85. 3 D Matix Inc 2007 10 3 D Matrix Inc 2009 4 ttp www sharedresearchjp 26 32 Shared 05Wesearch 2013 7 1 7777 TOP amp 2013 3 2013 3 21 ISO13485 ISO13485 ISO13485 TDM 621 ISO13485 TDM621
86. Millennium Research Group http www sharedresearch jp 18 32 Shared Wesearch se 2013 7 1 7777 2 000 3 5 6 1 60n 5 1 400 Proaprietary 8 0 1 200 Nonproprietary 9 1 000 95 a00 1 1 2 8 500 400 146W 30n Millenmium RR ch Group Prodhnomthrt 0 010 2 SB 09 010 01 1 01 013 014 MIT CSL
87. 2013 4 20 SR 60 TDM 621 1 3 2 3 TDM 621 20 85 x1 3 TDM 621 30 85 x1 3 20 SR 170 1 000 SR
88. 498 98 14 26 7 52 149 150 TDM 621 2011 5 PMDA TDM 621 1 4538 TDM 621
89. CE 2013 5 15 http goo g eSufu 2013 5 31 1 2 2013 4 19 2013 4 http goo gl J9ADx http goo gl pDeir m 2013 4 32 1 850 1 077 152 http7Xwww sharedresearchJp 2 32 s Shared Wesearch 2013 7 1 7777 1 069 160 1 070 130 2011 5 TDM 621
90. 2013 4 2 m PMDA m m m 15O13485 http7 www sharedresearchjp 20 32 Shared 05Wesearch 2013 7 1 7777 m m FDA m EU CE FDA m 2013 4 1 2012 9 13 2013 4 1 0 232 232
91. 7 1 758 1 1 5 2 354 999 1 658 PMID 9 11 0 3 5 7 dB 17 5B 50 510 310 97 1 646 a 28 0 939 3 1 21 1 1 296 61 584 309 978 1 491 27 9 35 7 SR a http www sharedresearch jp 23 32 Sh ared 8 esearch 201377 1 QB 4 10 4
92. 14 17 07 01 13 754 1 05 16 13 2370 06 11 13 3664 05 21 13 4680 06 07 13 4681 07 01 13 6920 05 28 13 94 19 06 25 13 2769 06 05 13 7455 06 13 13 2593 07 01 13 9384 05 28 13 2362 06 10 13 6063 05 23 13 2353 06 17 13 6157 06 25 13 8233 07 01 13 1 st 3644 05 28 13 GCA 2174 07 01 13
93. 2013 5 28 http goo g OR8sf m m 5263756 mm 3 2 3
94. 1235 9 18 5 1 249 1987 1 9 9 9 1 65 5 1 6546 UL 9 1 491 SR TDM 621 TDM 621 TDM 621 2014 4 TDM 621 2013 4
95. TDM 621 pH
96. 4 747 4 178 2015 4 8 006 8 474 TDM 621 4 32 http7Xwww sharedresearchJp Shared Wesearch 201377 1 7777 2014 4 ae 2015 4 2014 4 4 178 2014 4 2015 4 2014 4 TDM 621
97. ORRA MR MRT GUE 9 1 2 1 a http7 www sharedresearchjp 10 32 Shared 8 esearch 2013 7 1 7777 TDM 621 2010 1 97 2011 4 TDM 621 5 gt 7
98. RADA 16 pH ADME 30 DDS MIT MIT
99. m PMDA m m m mm m ISO13485 2013 3 21 mm m FDA 2013 2 2014 4 m U CE 2013 4 2014 4 mm FDA m 2013 4 2 2012 12 13 2013 4 2 2
100. 0 458 458 452 182 269 533 34 19 971 27 79 TDM 621 PMDA TDM 621 2012 4 9 2012 9
101. TDM 511 2015 4 Massachusetts Insttute of Technology MIT 1 4 1 MIT MIT 2 P
102. TDM 621 PMDA TDM 621 PMDA 2011 3 D Matix Inc TDM 711 FDA IDE TDM 641 2012 TDM 711 2012 Ly J Ul MM m m mo h TDM 621 2012 3 D Matrix Europe SAS 2012 3 D Matrix 10 Asia Pte Ltd TDM 621 FDA LIDE 0 ISO13485 4 2 2013 PT Teguhsindo Lestaritama TDM 621
103. TDM 711 2011 7 FDA IDE 2011 4 158 2010 4 402 ASG 150 2010 4 400 641 2010 4 174 50 TDM 621 122 http7Xwww sharedresearchJp 22 32 s Shared Wesearch 2013 7 1 7777 482 2010 4 65 510 60 534 61 8 19 TDM 621 2010 4 2011 4
104. 2012 4 1 107 1 TDM 621 2 TDM 64 1 3 753 354 3 14 26 48 310 309 2012 4 300
105. 2013 4 m 2013 4 1 850 2 491 152 589 160 583 130 529 2011 5 TDM 621 PMDA 2013 4 2014 4 2013 4 2014 4 2013 4
106. 1 http www sharedresearch jp 27 32 s Shared Wesearch 2013 7 1 7777 2012 10 2012 10 15 m 3 D Matrix Asia Pte Ltd 2012 10 1009 2012 9 2012 9 6 Massachusetts Insttute of Technology MIT
107. 2013 2 2013 2 4 TDM 621 FDA IDE TDM 621 US01 2013 2 1 FDA IDE Investigatonal Device Exempton 1 000 2013 2 1
108. PMDA 2010 8 2010 9 Daewoong Pharmaceutical Co LTD PARTNERSHIP AGREEMENT Excelsior Medical Co Ltd LLCENSE AGREEMENT m TDM 711 2011 3 FDA IDE IDE 3 TOP 09 4 19 4 11 4 12 4 13 4 10 402 158 1 107 32 4 1 5 BI 5 5d9 5 7 1 1 9 9 111 99 95 1 5 55 MI 499 ah
109. 9 FDA IDE 2011 7 IDE 2012 2 Forsyth Institute f f 2012 6 1 5 FDA b TDM 511 TDM 511 TDM 511 1
110. PDF http www sharedresearch jp 7777
111. 06 28 13 84 23 05 27 13 8889 05 17 13 6754 06 03 13 9882 06 26 13 9787 07 01 13 4847 05 22 13 2492 05 08 13 6750 07 01 13 4849 06 20 13 HD 8016a 05 21 13 8016 07 01 13 4583 06 26 13 8060 05 07 13 4 763 05 31 13 8999 06 14 13 4321 06 03 13 6249 06 24 13 6287 07 01 13 8136 07 01 13 3770 06
112. 2015 4 TDM 711 2012 2 2015 4 http7 www sharedresearchjp 6 32 Shared 05Wesearch 2013 7 1 7777 TDM 511 2014 4 FDA 510 k 510 k m m SR
113. PMDA 2013 4 2014 4 2013 4 2014 4 2013 4 m 2013 4 2015 4 2014 4 4 747 4 495 2 055 1 691 2 049 1 685 1 752 1 441 201 5 4 2013 4 2014 4
114. 2012 11 2012 11 20 Compositons and methods for cardiac tssue protecton and regeneraton EP2089047 m 3 D Matix InC
115. EU EU CE mm TDM 711 2012 2 15 FDA am TDM 641 http www sharedresearch jp 3 32 Shared Wesearch 201377 1 7777 2013 4 14 3 13 3 4 178 7 1 0 2 144d 1 3 dg5 rB5
116. RSN N lt iace eu 1 2 3 3
117. 2 20 m 2011 Phase 1 2012 4 3 1 http www sharedresearch jp 21 32 s Shared Wesearch 2013 7 1 7777 2012 3 9 2012 4 3 3 400 TDM 621 400
118. 25 TDM 621 CE FDA CE 2014 4 2014 4 TDM 711 2012 2 15 FDA m TDM 64 1 2013 4 i 2015 4 m 1
119. 26 13 3360 06 14 13 3046 06 05 13 2453 05 30 13 7777 07 01 13 9982 07 01 13 9793 06 11 13 4819 05 29 13 7532 06 10 13 7777 4571 06 25 13 6324 06 12 13 04 05 13 IS 4283 07 01 13 7956 07 01 13 2767 06 06 13 6890 06 11 13 24 12 06 10 13 9904 06 07 13 944 1 06 07 13 3730 05 31 13 7603 07 01 13
120. 3 1 137 785 013 2013 201474 2015 2016 KOL Key Opinion Leader mm 2015 4 2015 4 TDM 621 TDM 711 TDM 621 TDM 621
121. 55 3 020 12 15 2 0 n Q 0 31 49 112 913 0 Q 0 0 0 0 55 42 31 49 157 955 1 167 1 15Q 2 HHB 2 055 Q n Q 0 2 434 131 7 13 18 100 56 7 498 1 400 Ra 4 5 44 14 2 2 RQE 6 TOW 4 3 15 QB 7 7 BE IO 9W 7 3 W SR 2013 6 13 2013 4 htps www release tdnet info inbs 140120130613067293 pdf 2013 4
122. I 1 1 2 II 3 0 1 r LU 1 2 3 4
123. TDM 621 2011 5 PMDA TDM 621 1 4538 2012 4 1 4521 m TDM 711 2011 7 FDA IDE 2012 2 Forsyth Insttute m TDM 64 1 2012
124. ea 2o17AFa 5B Fura tr 20294Fg 16B gt 2008 11 a0 2021 2 5 Puraluatrix ooog 12 31 opoo 2 5 1E Puralufatrix USZOOE L0287185 PuraMatrk 507e29 2012 9 5 6 Puralulatrix 1F 50577B1 2012 9 5 EF 20BB047 2n12 11 2 PuraMatrik 1 526 756 Rs 2013 5 28 PCGT SR Purakatrix EE B h Matrix Inc MIT akMENDED MD RESTATED ERCLUSTWE PATENT LICENSE GREEIMENNT FIERST akMEKMDlMENT SECOhJD MENDIMHENIT THIRD MENDIMENT TO MENMDED kD
125. trix Inc 3 D Matix Inc MIT http7Xwww sharedresearchJp 14 32 s Shared Wesearch 2013 7 1 7777 emn Ei ott RE 1 US 54BGGQ MIT 20Q8 4 15 2017 21 Puralatrix WO 067014570 m 1EF EE CE a
Download Pdf Manuals
Related Search